| scholarly article | Q13442814 |
| P2093 | author name string | Kolb HJ | |
| Hiller E | |||
| Holler E | |||
| Stötzer O | |||
| Pihusch M | |||
| Pihusch R | |||
| Göhring P | |||
| Mühlbayer D | |||
| P2860 | cites work | Procalcitonin as a marker of the systemic inflammatory response to infection | Q34088242 |
| Coagulation inhibitors in sepsis and disseminated intravascular coagulation. | Q34148443 | ||
| Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease | Q40456999 | ||
| Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. | Q40460082 | ||
| Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock | Q40865699 | ||
| Time course of cytokine levels in sepsis | Q40990075 | ||
| Stimulation of human monocytes by anti-CD3 monoclonal antibody: induction of inflammatory mediator release via immobilization of Fc receptor by adsorbed immunoglobulin and T-lymphocytes | Q41592558 | ||
| Procalcitonin as a marker for the early diagnosis of severe infection after thermal injury. | Q43906926 | ||
| Immunosuppressive therapy in panmyelopathy. Experiences with various forms of therapy in 42 patients | Q44114464 | ||
| Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin | Q44146018 | ||
| Serum Cytokine Levels in Human Septic Shock | Q64127587 | ||
| Corticosteroid inhibition of the OKT3-induced cytokine-related syndrome--dosage and kinetics prerequisites | Q67983636 | ||
| Antithymocyte serum and methotrexate for control of graft-versus-host disease in dogs | Q69273159 | ||
| Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors | Q70051817 | ||
| High serum procalcitonin concentrations in patients with sepsis and infection | Q72211281 | ||
| Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies | Q74343272 | ||
| A new hypothesis of modular glucocorticoid actions: steroid treatment of rheumatic diseases revisited | Q74552357 | ||
| Monitoring anti-thymocyte globulin (ATG) in bone marrow recipients | Q77409054 | ||
| CRP levels in autoimmune disease can be specified by measurement of procalcitonin | Q77488408 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 347-354 | |
| P577 | publication date | 2002-09-01 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | The impact of antithymocyte globulin on short-term toxicity after allogeneic stem cell transplantation | |
| P478 | volume | 30 |
| Q40094493 | Anti-thymocyte globulin-induced hyperbilirubinemia in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation |
| Q45994507 | Antithymocyte antibody-induced coagulopathy in renal transplant recipients. |
| Q44160397 | Citrulline and albumin as biomarkers for gastrointestinal mucositis in recipients of hematopoietic SCT. |
| Q37995011 | Complications of autologous hematopoietic stem cell transplantation for patients with autoimmune diseases. |
| Q55438228 | Cytokine release syndrome. |
| Q44511393 | Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML. |
| Q35894544 | Hepatotoxicity induced by horse ATG and reversed by rabbit ATG: a case report |
| Q92454801 | Hurdles to Cardioprotection in the Critically Ill |
| Q53782053 | IgG antibodies to ATG early after pediatric hematopoietic SCT increase the risk of acute GVHD. |
| Q38096877 | Inflammatory markers in patients after hematopoietic stem cell transplantation |
| Q45026907 | Kinetic of procalcitonin in the early postoperative course following heart transplantation |
| Q46873982 | Management of patients transferred to the ICU during the conditioning phase of allogeneic hematopoietic stem cell transplantation |
| Q33422771 | Mechanism of Platelet Activation and Hypercoagulability by Antithymocyte Globulins (ATG). |
| Q51781590 | Monoclonal antibodies generated by DNA immunization recognize CD2 from a broad range of primates. |
| Q73356977 | Non-overt disseminated intravascular coagulation in patients during treatment with antithymocyte globulin for unrelated allogeneic hematopoietic stem cell transplantation |
| Q40173834 | Outcomes of peripheral blood stem cell transplantation patients from HLA-mismatched unrelated donor with antithymocyte globulin (ATG)-Thymoglobulin versus ATG-Fresenius: a single-center study |
| Q104795240 | Overt gastrointestinal bleeding following haploidentical haematopoietic stem cell transplantation: incidence, outcomes and predictive models |
| Q51000653 | Population pharmacokinetic modeling of Thymoglobulin(®) in children receiving allogeneic-hematopoietic cell transplantation: towards improved survival through individualized dosing. |
| Q80977556 | Protein C and procollagen III peptide levels in patients with hepatic dysfunction after allogeneic hematopoietic stem cell transplantation |
| Q92860787 | Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel |
| Q44723596 | Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation--a retrospective analysis |
| Q37510948 | Safety of conditioning agents for allogeneic haematopoietic transplantation |
| Q40446535 | Serial measurement of presepsin, procalcitonin, and C-reactive protein in the early postoperative period and the response to antithymocyte globulin administration after heart transplantation |
| Q40488546 | Subcutaneous alemtuzumab vs ATG in adjusted conditioning for allogeneic transplantation: influence of Campath dose on lymphoid recovery, mixed chimerism and survival |
| Q97521738 | Targeting the NLRP3 Inflammasome in Severe COVID-19 |
| Q40149764 | The efficacy and safety of rabbit anti-thymocyte globulin vs rabbit anti-T-lymphocyte globulin in peripheral blood stem cell transplantation from unrelated donors |
Search more.